Research Article

The Preoperative Assessment of Hepatic Tumours: Evaluation of UK Regional Multidisciplinary Team Performance

Table 3

Discrepant diagnoses in 42 patients.

MDT diagnosisHistological diagnosis
Total discrepantAngiomyolipoma* 
(1)
Benign cyst* (4)Benign fibrosis* (3)Bile duct papilloma* (1)Breast metastasis (3)Peripheral cholangiocarcinoma (11)CRM (270)FNH* (6)Focal fat* (2)Haemangioma* (9)Hepatoma (34)NET (13)No lesion* (2)Sarcoma (4)Chronic inflammation* (1)Ovarian metastasis (5)Xanthogranulomatous cholecystitis* (1)

Hepatoma (44)131511221
Colorectal metastases (CRM) (279)1021412
Hilar cholangiocarcinoma (31)72311
Metastases of unknown origin (6)5311
Breast metastases (3)3111
Peripheral cholangiocarcinoma (3)11
Anal metastases (7)11
Benign cyst (3)11
Gall bladder carcinoma (20)11

Total4212313911283221111

Total number of each diagnosis in the series (438) shown in brackets.
All MDT diagnoses of neuroendocrine tumours (NET) (11), focal nodular hyperplasia (FNH) (5), biliary cystadenoma (6), primary sarcoma (1), and haemangioma (1) were confirmed on histology.
Benign pathology.